Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

The shot was developed by Pfizer and targets the JN.1 sub-variant of Omicron. This is now the fifth iteration of the COVID vaccines, which have been updated regularly to keep up with the rapidly ...

The problem of fines not paid by anti-vaxxers in 2021. When the Draghi government imposed the vaccination obligation for ...

Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...

Health insurers use AI to deny certain claims and maximize their profits, a Senate report suggests. Hospitals around the country are struggling to fight back.

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

Hospital and ICU admission rates within 30 days after COVID-19 infection were greater in patients with inborn errors of immunity (IEI).

The vaccine is part of a recommended vaccine regimen for children ... and attempts to address the rise of FLiRT omicron ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

"At the height of the Omicron wave, we still saw a lot of children being hospitalized," Jennifer Nayak, MD, associate ...